Mobile

A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination with Chlorambucil, and that of Chlorambucil alone, in Patients with Chronic Lym...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000440-24

A Randomized, Multi-Center, Phase II Study to Investigate the Safety and Efficacy of SDX-101 (R-etodolac) in Combination with Chlorambucil, and that of Chlorambucil alone, in Patients with Chronic Lymphocytic Leukemia (CLL)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the overall response rate (Complete Response and Partial Response) of patients receiving chlorambucil with or without SDX-101 for the treatment of CLL.

Critère d'inclusion

  • Chronic lymphocytic leukemia (CLL)

Liens